Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy

OBJECTIVE: This study aimed to evaluate the utility of serum cancer antigen-125 (CA-125) levels to monitor patients with epithelial ovarian cancer (EOC) undergoing immune checkpoint inhibitor (ICI) therapy. METHOD: This was a single-center retrospective review of all patients with EOC who were treat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gynecol Oncol
Autors principals: Boland, Julia L., Zhou, Qin, Iasonos, Alexia E., O’Cearbhaill, Roisin, Konner, Jason, Callahan, Margaret, Friedman, Claire, Aghajanian, Carol, Sabbatini, Paul, Zamarin, Dmitriy, Cadoo, Karen A.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7423717/
https://ncbi.nlm.nih.gov/pubmed/32507515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2020.04.710
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars